AAAAAA

   
Results: 1-25 | 26-32 |
Results: 26-32/32
MINIMAL-CHANGE GLOMERULOPATHY AND GLOMERULAR VISCERAL EPITHELIAL HYPERPLASIA ASSOCIATED WITH ALPHA-INTERFERON THERAPY FOR CUTANEOUS T-CELL LYMPHOMA
Authors: TRAYNOR A KUZEL T SAMUELSON E KANWAR Y
Citation: A. Traynor et al., MINIMAL-CHANGE GLOMERULOPATHY AND GLOMERULAR VISCERAL EPITHELIAL HYPERPLASIA ASSOCIATED WITH ALPHA-INTERFERON THERAPY FOR CUTANEOUS T-CELL LYMPHOMA, Nephron, 67(1), 1994, pp. 94-100
IL1-ALPHA INCREASES THE CYTOTOXICITY OF THE IL2 DIPHTHERIA-TOXIN DAB389IL2 TOWARDS SEZARY-SYNDROME (SS) LYMPHOCYTES
Authors: SALARD D KUZEL T ROSEN S BAKOUCHE O
Citation: D. Salard et al., IL1-ALPHA INCREASES THE CYTOTOXICITY OF THE IL2 DIPHTHERIA-TOXIN DAB389IL2 TOWARDS SEZARY-SYNDROME (SS) LYMPHOCYTES, Blood, 84(10), 1994, pp. 10000429-10000429
A PHASE-I ESCALATING-DOSE SAFETY, DOSIMETRY AND EFFICACY STUDY OF RADIOLABELED MONOCLONAL-ANTIBODY LYM-1
Authors: KUZEL T ROSEN ST ZIMMER AM SILVERSTEIN EA SPIES S SALETAN SL NORVITCH ME BIRKHOFER M SHOCHAT D LOBUGLIO AF MEREDITH R KHAZAELI MB POLANSKY A HU E CHEN D LEE K WATKINS K
Citation: T. Kuzel et al., A PHASE-I ESCALATING-DOSE SAFETY, DOSIMETRY AND EFFICACY STUDY OF RADIOLABELED MONOCLONAL-ANTIBODY LYM-1, Cancer biotherapy, 8(1), 1993, pp. 3-16
DAB389IL-2 IS WELL TOLERATED AT DOSES INDUCING RESPONSE IN IL-2 RECEPTOR-EXPRESSING LYMPHOMAS
Authors: LEMAISTRE CF KUZEL T FOSS F HESKETH P SALEH M PLATANIAS L SCHWARTZ G CRAIG F TOLSON K WOODWORTH T
Citation: Cf. Lemaistre et al., DAB389IL-2 IS WELL TOLERATED AT DOSES INDUCING RESPONSE IN IL-2 RECEPTOR-EXPRESSING LYMPHOMAS, Blood, 82(10), 1993, pp. 10000137-10000137
2-CHLORODEOXYADENOSINE (2-CDA) IS AN ACTIVE SALVAGE THERAPY IN INDOLENT NON-HODGKINS-LYMPHOMA (NHL)
Authors: HOFFMAN M TALLMAN M JANSON D HAKIMIAN D KUZEL T GORDON L RAI KR
Citation: M. Hoffman et al., 2-CHLORODEOXYADENOSINE (2-CDA) IS AN ACTIVE SALVAGE THERAPY IN INDOLENT NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000142-10000142
PHASE-II TRIAL OF 2-CHLORODEOXYADENOSINE (2-CDA) FOR THE TREATMENT OFCUTANEOUS T-CELL LYMPHOMA (CTCL)
Authors: LEE E KUZEL T SAMUELSON E TALLMAN M ROENIGK H ROSEN S
Citation: E. Lee et al., PHASE-II TRIAL OF 2-CHLORODEOXYADENOSINE (2-CDA) FOR THE TREATMENT OFCUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 82(10), 1993, pp. 10000142-10000142
THE TREATMENT OF MYCOSIS-FUNGOIDES (MF) WITH ALL-TRANS-RETINOIC ACID (TRA)
Authors: KUZEL T ROENIGK H SAMUELSON E ROSEN S
Citation: T. Kuzel et al., THE TREATMENT OF MYCOSIS-FUNGOIDES (MF) WITH ALL-TRANS-RETINOIC ACID (TRA), Blood, 82(10), 1993, pp. 10000570-10000570
Risultati: 1-25 | 26-32 |